metastatic breast cancer at esmo 2022: tropics02, monarch 3 and synergy
Published 1 year ago • 995 plays • Length 5:37Download video MP4
Download video MP3
Similar videos
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
-
2:51
breast cancer trials of interest at esmo 2022
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
1:45
clincal trial highlights in breast cancer at esmo 2022
-
1:52
highlights from esmo breast cancer 2022
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
2:58
#esmo22 highlights on sacituzumab govitecan in hr /her2- metastatic breast cancer: tropics-02
-
1:03
key lectures from esmo breast cancer 2022
-
2:00
advances in antibody-drug conjugates for breast cancer at esmo 2022
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
2:46
sara tolaney, esmo 2022: clinical trial highlights in breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
10:44
esmo 2022: breast cancer highlights
-
1:39
treatment for her2 metastatic breast cancer
-
1:54
highlights in lung cancer at esmo 2022
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
2:30
clinical trials in breast cancer: pallas, monarch 3 and solar-1
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer